Vallon Pharmaceuticals Announces Appointment of Meenu Karson to Board of Directors
February 28, 2022 16:05 ET
|
Vallon Pharmaceuticals Inc.
Global biopharmaceutical industry senior executive with over 15 years of operational leadership with transactional and capital markets experience spanning both private and public large pharma and...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of SBPH, NTN, PTI and GLIBA Mergers
September 23, 2020 15:00 ET
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Spring Bank Pharmaceuticals, Inc. (NASDAQ GS: SBPH) regarding possible breaches...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of BMCH, BYFC, CGIX, and PTI Mergers
September 02, 2020 20:00 ET
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: BMC Stock Holdings, Inc. (NASDAQ GS: BMCH) regarding possible breaches of...
Proteostasis Therapeutics Announces Scientific Presentations on New Data at 30th Annual North American Cystic Fibrosis Conference
September 22, 2016 07:30 ET
|
Proteostasis Therapeutics, Inc
CAMBRIDGE, Mass., Sept. 22, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by...
Proteostasis Therapeutics Announces Closing of Follow-On Public Offering of Common Stock
September 14, 2016 16:03 ET
|
Proteostasis Therapeutics, Inc
CAMBRIDGE, Mass., Sept. 14, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused...
Proteostasis Therapeutics Announces Pricing of Public Offering of Common Stock
September 09, 2016 07:30 ET
|
Proteostasis Therapeutics, Inc
CAMBRIDGE, Mass., Sept. 09, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by...
Proteostasis Therapeutics Issues Mid-Year Corporate Update on Cystic Fibrosis Pipeline Programs
August 11, 2016 07:45 ET
|
Proteostasis Therapeutics, Inc
CAMBRIDGE, Mass., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by...